Cyclacel Pharmaceuticals, Inc.
Hedge Funds Holdings
Last updated:
Cyclacel Pharmaceuticals, Inc.‘s stocks are currently a part of 2 hedge funds’ portfolios, which represents 0% of the total amount of its stocks outstanding. This makes up a total of 424 shares of Cyclacel Pharmaceuticals, Inc.. Compared to the previous quarter, the number grew by Infinity% or 424 shares more. 2 hedge funds are new holders of Cyclacel Pharmaceuticals, Inc. stock in Q1 2023, it is 100% of total holders.
Hedge funds holding Cyclacel Pharmaceuticals (Q1 2017 – Q1 2023)
| Q1 2017 | 3 |
|---|---|
| Q2 2017 | 1 |
| Q3 2017 | 2 |
| Q4 2017 | 2 |
| Q1 2018 | 2 |
| Q2 2018 | 3 |
| Q3 2018 | 2 |
| Q4 2018 | 1 |
| Q1 2019 | 1 |
| Q2 2019 | 1 |
| Q3 2019 | 1 |
| Q4 2019 | 1 |
| Q1 2020 | 1 |
| Q2 2020 | 0 |
| Q4 2021 | 1 |
| Q1 2022 | 1 |
| Q2 2022 | 1 |
| Q3 2022 | 1 |
| Q4 2022 | 0 |
| Q1 2023 | 2 |
Hedge funds changes in Cyclacel Pharmaceuticals positions (Q1 2017 – Q1 2023)
| Q1 2017 | 1 | 0 | 1 | 0 | 1 |
|---|---|---|---|---|---|
| Q2 2017 | 0 | 0 | 0 | 2 | -1 |
| Q3 2017 | 1 | 0 | 0 | 0 | 1 |
| Q4 2017 | 0 | 1 | 0 | 0 | 1 |
| Q1 2018 | 0 | 1 | 0 | 0 | 1 |
| Q2 2018 | 1 | 1 | 0 | 0 | 1 |
| Q3 2018 | 0 | 0 | 0 | 1 | 1 |
| Q4 2018 | 0 | 1 | 0 | 1 | -1 |
| Q1 2019 | 0 | 1 | 0 | 0 | 0 |
| Q2 2019 | 0 | 0 | 1 | 0 | 0 |
| Q3 2019 | 0 | 1 | 0 | 0 | 0 |
| Q4 2019 | 0 | 0 | 1 | 0 | 0 |
| Q1 2020 | 0 | 0 | 1 | 0 | 0 |
| Q2 2020 | 0 | 0 | 0 | 1 | -1 |
| Q4 2021 | 1 | 0 | 0 | 0 | 0 |
| Q1 2022 | 0 | 0 | 1 | 0 | 0 |
| Q2 2022 | 0 | 0 | 1 | 0 | 0 |
| Q3 2022 | 0 | 1 | 0 | 0 | 0 |
| Q4 2022 | 0 | 0 | 0 | 1 | -1 |
| Q1 2023 | 2 | 0 | 0 | 0 | 0 |
Top 50 hedge fund holders of Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCCP)
| Hedge fund | Value | Shares owned | Portfolio share |
|---|---|---|---|
| UBS GROUP AG | 4K | 548 | 0.000% |